Elizabeth Holmes, a Stanford University dropout once likened to Steve Jobs, was forced to pay a $500,000 fine and give up her blood-testing company Theranos after securities regulators said she fraudulently raised more than $700 million from investors.

Turbulent economic and political eras may impact measures of citizen health, a new study found—leading some experts to wonder what will be uncovered when we collect data from President Donald Trump’s tenure.

As federal officials struggle to tackle exorbitant pharmaceutical prices, at least one drug’s manufacturers have pledged to slash prices of a potentially life-saving drug for its most at-risk patients.

As reimbursement challenges grow for outpatient imaging, many practices are struggling to remain afloat. However, with the right technology, it’s very possible to stay ahead of the curve.

One morning last year, a patient checked into a hospital in Canada as the first TAVR case of the day, and they were discharge by that evening. It was an eyebrow-raising feat for a procedure that typically requires several days of hospitalization.

As the "volume to value" movement reshapes healthcare economics across the U.S., radiology is reminded daily that it is by no means exempt from the new and somewhat nebulous fiscal demands.

A hospital seeking to replace CT technology that does not meet the XR-29 standard has a wide range of slice counts and capabilities to consider, all the way up to state-of-the-art—but pricey—dual energy CT (DECT).

April 16, 2015, marked the beginning of a seismic shift in the healthcare landscape. On that day, the U.S. Senate passed H.R. 2, the MACRA, which repeals the SGR formula, extends the CHIP for two years, institutes a 0.5% increase in Medicare reimbursement over the next four and a half years and encourages physicians to transition to APMs.